Phyton Biotech Continues to Expand its Team of Scientists
Dr. Marisol Ochoa-Villareal joins Phyton Biotech's R&D Team in Germany.
Organizational Changes at Phyton Biotech in Germany
Phyton Biotech is pleased to announce organizational changes at Phyton Biotech in Germany.
Phyton Biotech Expands Leadership Team with the Appointment of a New Vice President of Business Development
Phyton Biotech will showcase its specialty fermentation solutions at CPhI Worldwide online and in-person, this October and November.
Phyton Biotech to Showcase Specialty Fermentation at CPhI Worldwide
Phyton Biotech will showcase its specialty fermentation solutions at CPhI Worldwide online and in-person, this October and November.
Phyton Biotech has received Regulatory Approval from China’s NMPA for its plant cell fermentation-derived Paclitaxel Active Pharmaceutical Ingredient.
Phyton Biotech is pleased to announce approval from China’s regulatory body – National Medical Products Administration (NMPA) - for Phyton’s Drug Master File for paclitaxel active pharmaceutical ingredient produced via plant cell fermentation (PCF®).
Phyton Biotech Announces the Successful Establishment of Plant Cell Lines to Source Key Building Block for Treatment of Rare Dermatologic Conditions
Phyton Biotech’s Plant Cell Fermentation (PCF) technology has been successfully used to develop high-yielding plant cell lines of the source of cyclopamine, a key raw material for PellePharm’s patedigib topical gel.